Specifically, rs28714259 dysregulates multiple genes important to attenuated cardiac hypertrophy signaling and their convergence on canonical pathways such as GPCR/cAMP/PKA and MAPK/ERK1/2/ERK5. The gene discussed is MAPK3; the disease is cardiac hypertrophy.